CUSIP: 019621200
Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
1,317,933
-
Share change
-
-507,271
-
Total reported value
-
$7,249,000
-
Price per share
-
$5.50
-
Number of holders
-
13
-
Value change
-
-$4,980,204
-
Number of buys
-
5
-
Number of sells
-
8
Quarterly Holders Quick Answers
What is CUSIP 019621200?
CUSIP 019621200 identifies ALQA - ALLIQUA BIOMEDICAL INC - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2014
-
Previous quarter:
Q1 2014
Recent filing periods for CUSIP 019621200:
Institutional Holders of ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) as of Q2 2014
As of 30 Jun 2014,
ALLIQUA BIOMEDICAL INC - COM NEW (ALQA) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,317,933 shares.
The largest 10 holders included
J. Goldman & Co LP, SUFFOLK CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, JHL Capital Group LLC, GEODE CAPITAL MANAGEMENT, LLC, Edge Wealth Management LLC, SPRINGBOK CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, and BlackRock Investment Management, LLC.
This page lists
13
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.